Group 1 - The company has successfully acquired exploration rights for the natural soda ash mine in Jilantai Town, Alxa Left Banner, Inner Mongolia, through a public auction for RMB 929,000 [1] - The geological analysis indicates the potential presence of soluble inorganic salt natural soda ash in the exploration area, which is located in a geologically favorable position with significant sediment thickness and stable deposition conditions [1] - The exploration area is situated in the Jilantai depression, which has a complete development of Triassic strata and extensive Upper Cretaceous strata, suggesting favorable conditions for the formation of natural soda ash deposits [1] Group 2 - The company will conduct further exploration to assess the viability of transitioning from exploration to extraction based on the findings [2] - The company emphasizes the importance of ongoing monitoring of the exploration progress and will fulfill its information disclosure obligations to investors [2]

Group 1: Company Announcements - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international brand image [1] - Saisir reported June sales of 46,086 new energy vehicles, a year-on-year increase of 4.44%, with a total of 172,100 units sold in the first half of the year, down 14.35% year-on-year [1] - Hangzhou High-tech announced a change in controlling shareholder to Jirong Weiye, with stock resuming trading on July 2, 2025 [1] Group 2: Financial Performance - Guomai Technology expects a net profit of 125 million to 156 million yuan for the first half of 2025, a year-on-year increase of 60.52% to 100.33% [2] - Kid King anticipates a net profit of 120 million to 160 million yuan for the first half of 2025, representing a year-on-year growth of 50% to 100% [2] - Mould Technology received a project from a well-known North American electric vehicle company, with expected total sales of 1.236 billion yuan over five years [3] Group 3: Regulatory and Compliance - *ST Yuancheng is under investigation by the China Securities Regulatory Commission for suspected false disclosures in financial reports [4] - The company received a notice of investigation on July 1, 2025, which may lead to significant penalties and potential delisting [4] Group 4: Market Activity - Changcheng Military Industry's stock has experienced significant volatility, with a cumulative price deviation exceeding 20% over three trading days, indicating potential irrational speculation [5] - Anglikang has only one innovative drug project, ALK-N001, currently in Phase I clinical trials, highlighting the long and uncertain nature of drug development [6] Group 5: Sales and Contracts - Beiqi Blue Valley's subsidiary reported a 139.73% year-on-year increase in sales for the first half of the year [7] - Dong'an Power's engine sales in June increased by 82.79% year-on-year [7] - Pudong Construction's subsidiary won multiple major projects with a total bid amount of 1.964 billion yuan [7]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

证券代码：600328 证券简称：中盐化工 公告编号：2025-055 中盐内蒙古化工股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/12/7 | | --- | --- | | 回购方案实施期限 | 用于员工持股计划或股权激励用途的， 待股东大 | | | 会审议通过后 12 个月 ；用于维护公司价值及股 | | | 东权益用途的，待股东大会审议通过后 个月。 3 | | 预计回购金额 | 5,000万元~10,000万元 | | 回购用途 | □减少注册资本 | | | √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | √为维护公司价值及股东权益 | | 累计已回购股数 | 903.657万股 | | 累计已回购股数占总股本比例 | 0.616% | | 累计已回购金额 | 6,704.11万元 | | 实际回购价格区间 | 6.71元/股~7.98元/股 | 本次回购符合相关法律法规和公司回购股份方案的要求。 关于以集中竞价交易 ...

1.勘查项目名称：内蒙古自治区阿拉善左旗吉兰泰镇天然碱矿普查探矿 权 证券代码：600328 证券简称：中盐化工 公告编号：（临）2025-056 中盐内蒙古化工股份有限公司 关于竞拍获得探矿权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、取得探矿权的基本情况 2025 年 5 月 15 日，内蒙古自治区自然资源网上交易系统公开挂牌出让 内蒙古自治区阿拉善左旗吉兰泰镇天然碱矿普查探矿权（以下简称"吉兰 泰天然碱探矿权"）。该勘查区块从地质构造特征和沉积学等方面分析， 存在可溶性无机盐天然碱的可能，为此在吉兰泰区域进行风险勘探，以期 发现可溶性天然碱矿藏。区块所处的吉兰泰凹陷位于河套盆地临河坳陷南 部，三叠系地层发育齐全，厚度巨大；白垩系上部地层在该区域广覆式发 育；勘查规划区块所处构造位置位于吉兰泰凹陷相对较低位置（海拔相对 低位置），沉积厚度大，地层层序全，沉积稳定，对地层判断和无机盐储 存在条件有利。根据相关地质资料分析，吉兰泰凹陷白垩系地层中含有大 量碳酸盐岩，与同一地质年代形成的天然碱矿具有相类似的 ...

中盐化工（600328）公告，2025年6月30日，公司通过公开竞拍方式，以人民币92.9万元获得内蒙古自 治区阿拉善左旗吉兰泰镇天然碱矿普查探矿权。探矿权勘查项目名称为吉兰泰天然碱探矿权，探矿权人 为中盐内蒙古化工股份有限公司，勘查面积为14.57平方公里，出让期限为5年。 ...

Core Viewpoint - On June 30, a total of 31 listed companies had their restricted shares unlocked, with a total market value of approximately 31.50 billion yuan [1]. Group 1: Unlocking Details - The specific details of the restricted share unlocks include: - Meili Ecology (000010): 239 million shares from A-share issuance to original shareholders - Xingrong Environment (000598): 4.926 million shares from equity incentive lock-up - Yueyang Xinchang (000819): 526,800 shares from equity incentive lock-up - Gaohong Co., Ltd. (000851): 4.944 million shares from equity incentive lock-up - Zhongyan Chemical (600328): 470,460 shares from equity incentive lock-up - Yangnong Chemical (600486): 115,480 shares from equity incentive lock-up - Kangyuan Pharmaceutical (600557): 2.6093 million shares from equity incentive lock-up - Keda Technology (002518): 1.3953 million shares from equity incentive lock-up - Longci Technology (300835): 562,700 shares from equity incentive lock-up - Weiming Environmental Protection (603568): 3.129 million shares from equity incentive lock-up - Dongrui Co., Ltd. (001201): 486,400 shares from A-share issuance to original shareholders - Sanwei Co., Ltd. (603033): 1.183 million shares from equity incentive lock-up - Naer Co., Ltd. (002825): 140,000 shares from equity incentive lock-up - Jinyinhe (300619): 1.6248 million shares from A-share issuance to legal persons - Tianyuan Environmental Protection (301127): 14.6 million shares with extended lock-up period - Youningwei (301166): 40.6188 million shares with extended lock-up period - Xutian Salt Industry (600929): 3.033 million shares from equity incentive lock-up - Keli Sensor (603662): 722,800 shares from equity incentive lock-up - Gongniu Group (603195): 641,200 shares from equity incentive lock-up - Fuyuan Pharmaceutical (601089): 27.5 million shares from pre-issue lock-up - Xinbang Intelligent (301112): 7.4097 million shares from pre-issue lock-up - Shanghai Port Bay (605598): 29,400 shares from equity incentive lock-up - Dingjide (603255): 507,500 shares from equity incentive lock-up - United Precision (001268): 6.154 million shares from pre-issue lock-up - Pinggao Co., Ltd. (688227): 48.9585 million shares - Chunli Medical (688236): 20.9 million shares - Zhongwulian (688297): 40.3 million shares - Lais Information (688631): 163,480 shares - Shichuang Energy (688429): 200,000 shares - Xindong Link (688582): 220,840 shares - Aike Saibo (688719): 100,000 shares [2].

Project Overview - The project is named "Boiler Flue Gas Ultra-Low Emission Technology Renovation Project" at Zhongyan Qinghai Kunlun Soda Industry Co., Ltd [1][2] - The total investment for the project is 84.4395 million yuan, with 30% funded by the company’s own funds and 70% through bank loans [2][5] - The construction period is planned for 12 months [3] Project Necessity - The project aligns with national and local environmental protection policies, aiming for ultra-low emissions from coal-fired power plants by 2020 [3][4] - Existing desulfurization and denitrification facilities at Kunlun Soda have been in operation for 13 years, leading to decreased efficiency due to equipment aging [4] Project Benefits - Implementation of the project will ensure that boiler flue gas emissions meet national ultra-low emission standards, enhancing the company's image and product competitiveness [4] - The project will eliminate risks associated with aging environmental protection equipment, ensuring stable operation of Kunlun Soda's production facilities [4] Risk Analysis and Mitigation - The project is compliant with all legal and regulatory requirements, indicating no policy risks [5] - The technology employed is mature and widely used in the industry, resulting in low technical risk [5] - Construction will occur within the existing production site, which may pose safety risks; however, measures such as safety assessments and operational time segregation will be implemented to mitigate these risks [5] Impact on the Company - The project supports the company's sustainable and high-quality green development, providing significant ecological benefits [5]

Core Points - The company has established a Board Strategic and ESG Committee to enhance decision-making processes and improve the quality of major investment decisions, while promoting sustainable development and strengthening core competitiveness [1][2] - The committee is composed of seven directors, including at least one independent director, and is responsible for formulating long-term development strategies and major investment project reports [1][2] Group 1: Committee Structure - The committee members are nominated by the chairman and elected by more than half of the board members [2] - The committee's term aligns with that of the board, and if a member ceases to be a director, they automatically lose their committee position [2] - The committee includes an Investment Review Group led by the general manager and an ESG Working Group led by the board secretary [2][4] Group 2: Responsibilities and Authority - The committee's main responsibilities include researching and proposing long-term development strategies, major investment decisions, and ESG governance matters [3][8] - It is tasked with identifying sustainable development risks and opportunities, conducting research and risk assessments related to ESG, and supervising the implementation of ESG policies [3][8] - The committee is also responsible for reviewing and submitting ESG-related reports to the board [3][8] Group 3: Decision-Making Procedures - The Investment Review Group prepares preliminary work for strategic decisions, including reviewing major investment proposals and issuing opinions [4][5] - The ESG Working Group compiles ESG management systems and annual reports, submitting formal proposals to the committee [5] - The committee holds meetings to discuss proposals from both groups and provides feedback [5][6] Group 4: Meeting Rules - The committee is required to meet at least twice a year, with meetings convened by the chairperson or an independent director in their absence [7][8] - A quorum requires the presence of at least two-thirds of the members, and decisions must be approved by a majority [7][8] - Meeting records are maintained, and all attendees are bound by confidentiality regarding the discussed matters [8][9] Group 5: Implementation and Amendments - The implementation details of the committee are subject to national laws and regulations, and any conflicts with future laws will be resolved accordingly [10] - The committee's rules were first established in April 2024 and revised in June 2025 [10]

第二条 审计委员会是董事会设立的专门委员会，行使《公司法》规定的监事会 的职权，负责审核公司财务信息及其披露、监督及评估内外部审计工作和内部控制。 中盐内蒙古化工股份有限公司 董事会审计委员会实施细则 （2025 年 6 月修订） 第一章 总 则 第一条 为提高中盐内蒙古化工股份有限公司（以下简称"公司"）治理水平， 进一步完善公司治理结构，健全公司内部监督机制，强化董事会决策功能，降低董事 会决策风险，根据《中华人民共和国公司法》（以下简称《公司法》）、《上市公司章程 指引》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》《上市公司审计 委员会工作指引》等有关法律法规和规范性文件，以及《中盐内蒙古化工股份有限公 司章程》（以下简称《公司章程》）规定，公司特设立董事会审计委员会，并制定本实 施细则。 第三条 审计委员会成员应当保证足够的时间和精力履行委员会的工作职责，勤 勉尽责，切实有效地监督、评估公司内外部审计工作，促进公司建立有效的内部控制 并提供真实、准确、完整的财务报告。 第四条 公司应当为审计委员会提供必要的工作条件，配备专门人员或者机构承 担审计委员会的工作联络、会议组织、材料准备和档 ...